1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Renal Failure Global Clinical Trials Review, H1, 2015

Renal Failure Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 121 pages

Renal Failure Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H1, 2015" provides data on the Renal Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Renal Failure Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Renal Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Failure 25
Subjects Recruited Over a Period of Time 41
Clinical Trials by Sponsor Type 42
Prominent Sponsors 43
Top Companies Participating in Renal Failure Therapeutics Clinical Trials 44
Prominent Drugs 45
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
Sanofi 46
Clinical Trial Overview of Sanofi 46
Amgen Inc. 51
Clinical Trial Overview of Amgen Inc. 51
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
AbbVie Inc. 63
Clinical Trial Overview of AbbVie Inc. 63
Pfizer Inc. 67
Clinical Trial Overview of Pfizer Inc. 67
AstraZeneca PLC 70
Clinical Trial Overview of AstraZeneca PLC 70
Shire Plc 72
Clinical Trial Overview of Shire Plc 72
Abbott Laboratories 74
Clinical Trial Overview of Abbott Laboratories 74
Johnson and Johnson 76
Clinical Trial Overview of Johnson and Johnson 76
Clinical Trial Overview of Top Institutes / Government 78
Vanderbilt University 78
Clinical Trial Overview of Vanderbilt University 78
Seoul National University Hospital 80
Clinical Trial Overview of Seoul National University Hospital 80
University of Michigan 81
Clinical Trial Overview of University of Michigan 81
Medical University of Vienna 82
Clinical Trial Overview of Medical University of Vienna 82
The National Institute of Diabetes and Digestive and Kidney Diseases 83
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 83
Yonsei University 84
Clinical Trial Overview of Yonsei University 84
Tehran University of Medical Sciences 86
Clinical Trial Overview of Tehran University of Medical Sciences 86
National Taiwan University Hospital 87
Clinical Trial Overview of National Taiwan University Hospital 87
Ghent University Hospital 88
Clinical Trial Overview of Ghent University Hospital 88
Isfahan University of Medical Sciences 89
Clinical Trial Overview of Isfahan University of Medical Sciences 89
Five Key Clinical Profiles 90
Appendix 119
Abbreviations 119
Definitions 119
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 121

List of Tables

Renal Failure Therapeutics, Global, Clinical Trials by Region, 2015* 7
Renal Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Renal Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Renal Failure Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Renal Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Renal Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Failure Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Renal Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Failure Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Renal Failure Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Renal Failure Therapeutics, Global, Terminated Clinical Trials, 2015* 30
Renal Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 41
Renal Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 42
Renal Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 43
Renal Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 44
Renal Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 45
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 46
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 51
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 55
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 63
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 67
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 70
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 72
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 74
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 76
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 78
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 80
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 81
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 82
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 83
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2015* 84
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 86
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 87
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 88
Renal Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 89

List of Figures

Renal Failure Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Renal Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Renal Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Renal Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Renal Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Renal Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Failure to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Renal Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Renal Failure Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Failure Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 41
Renal Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 42
Renal Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 43
Renal Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 44
Renal Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 45
GlobalData Methodology 120

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Proteinuria is a result of an excess of serum proteins in the urine, which can led to renal damage. The most common cause of proteinuria is diabetes. Globally, development the arena of proteomics and ...

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

Benign prostatic hyperplasia (BPH)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Benign prostatic hyperplasia (BPH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

Endometriosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Endometriosis Industry

October 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.